Instil Bio, Inc. (TIL)
Data as of , from SEC Form 4 filings.
See up to 3 months of TIL. The 7-day demo opens the 1M and 3M ranges and puts TIL on your watchlist.
Start 7-day demoLatest TIL insider trades
- Sandeep Laumas - OfficerOpen-market sale$404K
- Sandeep Laumas - OfficerOpen-market sale$298K
R. Kent McGaughy Jr. - Director
About Instil Bio, Inc. (TIL)
Instil Bio, Inc. is an SEC registrant, filing under CIK 0001789769, classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
TIL Form 4 activity by transaction type, last 90 days
No Form 4 activity for TIL in the last 90 days.
TIL insider transactions (Form 4)
105 Form 4 filings on record, the earliest from Sep 10, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| R. Kent McGaughy Jr. - Director | Grant or award | Stock Option (Right to Buy) | 6,500 | $0.00 | - | |
| George Matcham - Director | Grant or award | Stock Option (Right to Buy) | 6,500 | $0.00 | - | |
| Neil W. Gibson - Director | Grant or award | Stock Option (Right to Buy) | 0 | $0.00 | - | |
| Gwendolyn Binder - Director | Grant or award | Stock Option (Right to Buy) | 6,500 | $0.00 | - | |
| Sandeep Laumas - Officer | Option exercise | Common Stock | 17,000 | $11.60 | $197K | |
| Sandeep Laumas - Officer | Option exercise | Common Stock | 13,000 | $12.68 | $165K | |
| Sandeep Laumas - Officer | Open-market sale | Common Stock | 17,539 | $23.04 | $404K | |
| Sandeep Laumas - Officer | Open-market sale | Common Stock | 12,461 | $23.88 | $298K | |
| Sandeep Laumas - Officer | Option exercise | Employee Stock Option (right to buy) | 17,000 | $0.00 | - | |
| Sandeep Laumas - Officer | Option exercise | Employee Stock Option (right to buy) | 13,000 | $0.00 | - |
TIL insider trading FAQ
What is the latest insider trade for TIL?
Instil Bio, Inc. (TIL) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-12. The full record for TIL runs to 5 Form 4 filings, the earliest from 2025-09-10. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying TIL stock?
No insider purchases of TIL were filed in the last 90 days.
How many insiders are selling TIL stock?
No insider sales of TIL were filed in the last 90 days. 2 sales are on record for this company.
Where can I see TIL SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects TIL Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
5The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - R. Kent McGaughy Jr. view on EDGAR
- - George Matcham view on EDGAR
- - Neil W. Gibson view on EDGAR
- - Gwendolyn Binder view on EDGAR
- - Sandeep Laumas view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where TIL's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow TIL with a 7-day demo
- TIL on your watchlist
- Every TIL Form 4 filing on record
- Up to 3 months of TIL price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
